<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dermatologic manifestations are among the most common signs of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>The Hopkins <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> Cohort study is a prospective study in which patients with SLE are seen on a quarterly basis for measurement of disease activity, laboratory tests, and assessment of morbidity and quality of life </plain></SENT>
<SENT sid="2" pm="."><plain>This cohort has allowed unique insights into the epidemiologic factors of SLE, the presentation of dermatologic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, and morbidity, <z:hpo ids='HP_0000001'>all</z:hpo> of which are presented in this report </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, the dermatologic signs of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (APS) are reviewed </plain></SENT>
<SENT sid="4" pm="."><plain>Approaches to treatment of dermatologic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and APS are discussed </plain></SENT>
</text></document>